Sorrento Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2023.
  • Sorrento Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$77.2M, a 34.7% increase year-over-year.
  • Sorrento Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$463M, a 4.85% decline year-over-year.
  • Sorrento Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$504M, a 25.6% decline from 2021.
  • Sorrento Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$401M, a 64.2% decline from 2020.
  • Sorrento Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$245M, a 5.74% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$463M -$77.2M +$41.1M +34.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$504M -$106M +$539K +0.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$504M -$170M -$55M -48% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$449M -$109M -$8.06M -7.95% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$441M -$118M -$17.8M -17.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$423M -$107M -$22M -25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$401M -$115M -$44.1M -62.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$357M -$101M -$18.3M -22% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$339M -$101M -$52.8M -111% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$286M -$84.9M -$41.7M -96.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$245M -$70.5M -$37.9M -116% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$207M -$83.1M -$29.8M -56% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$177M -$47.7M +$2.63M +5.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$179M -$43.2M +$80M +65% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$259M -$32.6M +$9.02M +21.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 -$268M -$53.3M -$5.38M -11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$263M -$50.4M -$22M -77.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$241M -$123M -$90.6M -278% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$150M -$41.6M -$6.8M -19.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 -$144M -$47.9M -$145M -149% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.2M -$28.4M -$14.9M -111% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $16.1M -$32.5M -$9.22M -39.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $25.3M -$34.8M -$17M -95.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $42.3M $96.9M +$109M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$66.8M -$13.5M +$31.3M +69.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$98.1M -$23.3M -$1.31M -5.96% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$96.8M -$17.8M -$142K -0.8% Oct 1, 2016 Dec 31, 2016 8-K 2019-06-17
Q3 2016 -$96.6M -$12.2M +$23.4M +65.6% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-27
Q2 2016 -$120M -$44.7M -$34.2M -324% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$85.8M -$22M -$11.8M -116% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$74M -$17.7M -$7.91M -81.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$66.1M -$35.6M -$28.5M -400% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$37.6M -$10.5M -$2.54M -31.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$35M -$10.2M -$303K -3.07% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$34.7M -$9.75M +$1.38M +12.4% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-27
Q3 2014 -$36.1M -$7.13M -$3.82M -116% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$32.3M -$7.99M -$3.27M -69.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$29M -$9.87M -$7.36M -293% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$21.7M -$11.1M -$9.37M -534% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$12.3M -$3.31M -$2.06M -166% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$10.2M -$4.72M -$3.77M -399% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$6.46M -$2.51M -$1.61M -177% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$4.85M -$1.76M -$993K -130% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$3.86M -$1.24M -$540K -76.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.32M -$945K +$144K +13.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$3.46M -$908K -$222K -32.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$3.24M -$763K Oct 1, 2011 Dec 31, 2011 10-K/A 2013-03-27
Q3 2011 -$704K -$258K -57.9% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-08
Q2 2011 -$1.09M -$513K -89% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$686K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$446K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$576K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.